Synthesizing AND gate genetic circuits based on CRISPR-Cas9 for identification of bladder cancer cells
- 6 November 2014
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature Communications
- Vol. 5 (1), 5393
- https://doi.org/10.1038/ncomms6393
Abstract
The conventional strategy for cancer gene therapy offers limited control of specificity and efficacy. A possible way to overcome these limitations is to construct logic circuits. Here we present modular AND gate circuits based on CRISPR-Cas9 system. The circuits integrate cellular information from two promoters as inputs and activate the output gene only when both inputs are active in the tested cell lines. Using the luciferase reporter as the output gene, we show that the circuit specifically detects bladder cancer cells and significantly enhances luciferase expression in comparison to the human telomerase reverse transcriptase-renilla luciferase construct. We also test the modularity of the design by replacing the output with other cellular functional genes including hBAX, p21 and E-cadherin. The circuits effectively inhibit bladder cancer cell growth, induce apoptosis and decrease cell motility by regulating the corresponding gene. This approach provides a synthetic biology platform for targeting and controlling bladder cancer cells in vitro.Keywords
This publication has 29 references indexed in Scilit:
- Self‐processing of ribozyme‐flanked RNAs into guide RNAs in vitro and in vivo for CRISPR‐mediated genome editingJournal of Integrative Plant Biology, 2014
- Genome engineering using the CRISPR-Cas9 systemNature Protocols, 2013
- Tunable and Multifunctional Eukaryotic Transcription Factors Based on CRISPR/CasACS Synthetic Biology, 2013
- RNA-Guided Human Genome Engineering via Cas9Science, 2013
- Synthesizing Biomolecule-Based Boolean Logic GatesACS Synthetic Biology, 2012
- Biomolecular computing systems: principles, progress and potentialNature Reviews Genetics, 2012
- Foundations for the design and implementation of synthetic genetic circuitsNature Reviews Genetics, 2012
- Development of targeted therapy for bladder cancer mediated by a double promoter plasmid expressing diphtheria toxin under the control of H19 and IGF2-P4 regulatory sequencesJournal of Translational Medicine, 2010
- A tunable dual‐promoter integrator for targeting of cancer cellsMolecular Systems Biology, 2010
- Bladder cancerThe Lancet, 2009